Gyre Therapeutics (GYRE) Change in Intangibles (2022 - 2026)
Gyre Therapeutics (GYRE) reported Change in Intangibles of $5000.0 for Q1 2026, down 99.28% year-over-year from $699000.0 in Q1 2025, and up 225.0% quarter-over-quarter from -$4000.0 in Q4 2025.
Gyre Therapeutics (GYRE) Change in Intangibles (2022 - 2026) Analysis & Trends
Gyre Therapeutics (GYRE) has 5 years of Change in Intangibles data on file, last reported at $5000.0 in Q1 2026.
- Change in Intangibles for Q1 2026 came in at $5000.0, down 99.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $39000.0 (down 97.42% YoY), and the FY2025 annual result was $733000.0, down 9.84% from the prior year.
- Change in Intangibles climbed to $5000.0 in Q1 2026 per GYRE's latest filing, from -$4000.0 in the prior quarter.
- Over five years, Change in Intangibles peaked at $810000.0 in Q4 2024 and troughed at -$55.0 million in Q4 2022.
- A 5-year average of -$4.9 million and a median of $5000.0 in 2026 frame the typical range for Change in Intangibles.
- The sharpest annual moves came in 2024 and 2025: Change in Intangibles surged 80900.0% in 2024, then plunged 100.49% in 2025.
- A 5-year view of Change in Intangibles shows it stood at -$55.0 million in 2022, then soared by 100.0% to $1000.0 in 2023, then surged by 80900.0% to $810000.0 in 2024, then sank by 100.49% to -$4000.0 in 2025, then soared by 225.0% to $5000.0 in 2026.
- Business Quant data shows GYRE's Change in Intangibles at $5000.0 in Q1 2026, -$4000.0 in Q4 2025, and $15000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.96 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Gyre Therapeutics | 554.75 Mn | 540.62 Mn | 8.38 Mn | 5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,000.00 |
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Sep 30, 2025 | 15,000.00 |
| Sep 30, 2025 | 15,000.00 |
| Jun 30, 2025 | 23,000.00 |
| Jun 30, 2025 | 23,000.00 |
| Mar 31, 2025 | 699,000.00 |
| Mar 31, 2025 | 699,000.00 |
| Dec 31, 2024 | 810,000.00 |
| Dec 31, 2024 | 810,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 65,000.00 |
| Mar 31, 2023 | 65,000.00 |